Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma

Human Pathology

Volumn 45, Issue 2, 2014, Pages 213-220

  Moreira, Andre L ^a   Joubert, Philippe ^a   Downey, Robert J ^a   Rekhtman, Natasha ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Complex gland; Cribriform; Grade

Indexed keywords

AGED; AMERICAN THORACIC SOCIETY CLASSIFICATION; ARTICLE; CANCER GRADING; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER SURVIVAL; CRIBRIFORM PATTERN; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EUROPEAN RESPIRATORY SOCIETY CLASSIFICATION; FEMALE; FUSED GLAND; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER CLASSIFICATION; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE;

ADENOCARCINOMA; COMPLEX GLAND; CRIBRIFORM; GRADE;

ADENOCARCINOMA; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 84892774781     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.10.011     Document Type: Article

References (30)

1. W.D. Travis, G. Sauter, E. Brambilla, H.K. Muller-Hermelink, and C.C. Harris Pathology and genetics of tumors of the lung, pleura, thymus and heart. World Health Organization classification of tumours 2004 IARC Press Lyon
2. N. Motoi, J. Szoke, and G.J. Riely et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis Am J Surg Pathol 32 2008 810 827
3. W.D. Travis, E. Brambilla, and M. Noguchi et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma J Thorac Oncol 6 2011 244 285
4. A. Yoshizawa, N. Motoi, and G.J. Riely et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Mod Pathol 25 2011 653 664
5. N. Kobayashi, S. Toyooka, and K. Ichimura et al. Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung J Thorac Oncol 3 2008 704 710
6. T. Miyoshi, Y. Satoh, and S. Okumura et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis Am J Surg Pathol 27 2003 101 109
7. J. Yim, L.C. Zhu, and L. Chiriboga et al. Histologic features are important prognostic indicators in early stages lung adenocarcinomas Mod Pathol 20 2007 233 241
8. G. Sica, A. Yoshizawa, and C.S. Sima et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors Am J Surg Pathol 34 2010 1155 1162
9. E.A. Rakha, M.E. El-Sayed, and A.H. Lee et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma J Clin Oncol 26 2008 3153 3158
10. J.I. Epstein, W.C. Allsbrook Jr., and M.B. Amin et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
11. L. Egevad, R. Mazzuchelli, and R. Montironi Implications of the International Society of Urological Pathology Modified Gleason Grading System Arch Pathol Lab Med 136 2012 426 433
12. P. Goldstraw, J. Crowley, and K. Chansky et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
13. N. Rekhtman, P.K. Paik, and M.E. Arcila et al. Clarifying the spectrum of driver mutations in biomarker verified squamous cell carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations Clin Cancer Res 13 2012 64 73
14. E. Thunnissen, M. Beasley, and A. Borczuk et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma: an international interobserver study Mod Pathol 25 2012 1574 1583
15. K. Kadota, Y.-C. Yeh, and K. Susuki et al. Cribriform pattern identifies a poor subset of acinar predominant tumors in stage 1 adenocarcinoma patients Mod Pathol 25 Supp 2 2012 479A
16. L. Xu, F. Tavora, and A. Burke Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung Am J Surg Pathol 37 2013 1100 1108
17. K. Kadota, K. Suzuki, and S.S. Kachala et al. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma Mod Pathol 25 2012 1117 1127
18. K. Kadota, C. Colovos, and K. Suzuki et al. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma Annals Surg Oncol 19 2012 3598 3605
19. A. Warth, T. Muley, and M. Meister et al. The novel histological IASLC/ATS/ERS classification system of lung adenocarcinoma is a stage independent predictor of survival J Clin Oncol 30 2012 1438 1446
20. J.H. Von der Thüsen, Y.S. Tham, and H. Pattenden et al. Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system J Thorac Oncol 8 2013 37 44
21. W. Sterlacci, S. Savic, and T. Schmidt et al. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact Am J Clin Pathol 137 2012 946 956
22. P.A. Russel, Z. Wainer, and G.M. Wright et al. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Association/European Respiratory Society international multidisciplinary lung adenocarcinoma classification J Thorac Oncol 6 2011 1496 1504
23. N. Dursun, J. Feng, and O. Basturk et al. Vacuolated cell pattern of pancreatobiliary adenocarcinoma: a clinicopathological analysis of 24 cases of a poorly recognized distinctive morphologic variant important in the differential diagnosis Virchows Arch 457 2010 643 649
24. D.F. Gleason, and G.T. Mellinger Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J Urol 111 1974 58 64
25. A. Warth, J. Cortis, and L. Fink et al. Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification Virchows Arch 461 2012 185 193
26. N. Rekhtman, D.C. Ang, and G.J. Riely et al. KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma Mod Pathol 26 2013 1307 1319
27. P.A. Russell, S.A. Barnett, and M. Walkiewicz et al. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients J Thorac Oncol 8 2013 461 468
28. A. Yoshida, K. Tsuta, and H. Nakamura et al. Comprehensive histologic analysis of ALK-rearranged lung caricnomas Am J Surg Pathol 35 2011 1226 1234
29. S.J. Rodig, M. Mino-kenudson, and S. Dacic et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in Western population Clin Cancer Res 15 2009 5216 5223
30. P.Y. Yip, B. Yu, and W.A. Cooper et al. Patterns of DNA mutations and ALK rearrangement in resected node negative adenocarcinoma J Thorac Oncol 8 2013 408 414